Effects of risperidone on lipid profile [1]

Annals of Pharmacotherapy

Volumn 41, Issue 5, 2007, Pages 899-900

  Khalili, Hossein ^a   Dashti Khavidaki, Simin ^a   Okhovatpour, Hadi ^a   Ghaeli, Padideh ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

RISPERIDONE;

ADULT; AGED; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CORRELATION COEFFICIENT; DATA ANALYSIS; HOSPITAL DISCHARGE; HUMAN; INFORMED CONSENT; LETTER; PRIORITY JOURNAL; SCHIZOPHRENIA; SIDE EFFECT; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; BODY MASS INDEX; CHOLESTEROL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; RISPERIDONE; SCHIZOPHRENIA; TRIGLYCERIDES; WEIGHT GAIN;

EID: 34248575019     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H669     Document Type: Letter

References (5)

1. Smith RC, Lindenmayer JP, Bark N, et al. Clozapine, risperidone, olanzapine, and conventional antipsychotic drug effects on glucose, lipids, and leptin in schizophrenic patients. Int J Neuropsychopharmacol 2005;8:183-94.
2. Meyer JM, Koro CE. The effects of antipsychotic therapy on serum lipids: a comprehensive review. Schizophr Res 2004;70:1-17.
3. Wirshing DA, Boyd JA, Meng LR, et al. The effects of novel antipsychotics on glucose and lipid levels. J Clin Psychiatry 2002;63:856-65.
4. Ghaeli P, Dufresne RL. Elevated serum triglycerides with clozapine resolved with risperidone in four patients. Pharmacotherapy 1999;19: 1099-101.
5. Lane HY, Liu YC, Huang CL, et al. Risperidone-related weight gain: genetic and nongenetic predictors. J Clin Psychopharmacol 2006;26:128-34.